Semnur Pharmaceuticals, Inc. (SMNR)
0.55
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
Semnur Pharmaceuticals Total Assets (Quarterly) : 1.943M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.943M |
| March 31, 2026 | 1.969M |
| December 31, 2025 | 1.346M |
| September 30, 2025 | 0.774M |
| June 30, 2025 | 0.5625M |
| March 31, 2025 | 9.148M |
| December 31, 2024 | 6.684M |
| September 30, 2024 | 8.924M |
| June 30, 2024 | 52.12M |
| Date | Value |
|---|---|
| March 31, 2024 | 51.35M |
| December 31, 2023 | 50.69M |
| September 30, 2023 | 90.15M |
| June 30, 2023 | 88.19M |
| March 31, 2023 | 86.96M |
| December 31, 2022 | 86.28M |
| September 30, 2022 | 85.76M |
| June 30, 2022 | 85.53M |
| March 31, 2022 | 0.4419M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Scilex Holding Co. | 253.56M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 31.62M |
| Shareholders Equity (Quarterly) | -29.67M |
| Debt to Equity Ratio | -0.7768 |
| Current Ratio | 0.1118 |
| Net Debt Paydown Yield | -3.50% |